Community-acquired pneumonia laboratory findings

Jump to navigation Jump to search

Pneumonia Main Page

Community-Acquired Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Community-acquired pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Severity Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Hospital Admission Decision

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Community-acquired pneumonia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Community-acquired pneumonia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Community-acquired pneumonia laboratory findings

CDC on Community-acquired pneumonia laboratory findings

Community-acquired pneumonia laboratory findings in the news

Blogs on Community-acquired pneumonia laboratory findings

Directions to Hospitals Treating Community-acquired pneumonia

Risk calculators and risk factors for Community-acquired pneumonia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

While chest X-ray and pulse oximetry are routine tests among all patients with suspected pneumonia, additional laboratory tests (such as blood culture and gram sputum, sputum blood culture and gram stain, urinary antigen tests) are optional tests unless their results might alter the treatment plan.

Laboratory Tests

Specific indications for additional testing in patients with pneumonia
Diagnostic Test Indications
Sputum Culture
Blood Culture
Urinary Antigen Test for Pneumococcus
Urinary Antigen Test for Legionella
Adapted from IDSA/ATS Guidelines for CAP in Adults[1]

Routine Tests

Findings in routine blood tests are based on the severity of the disease and the cause, they can include the following:[2]

Sputum Gram Stain and Culture

  • Sputum samples should be obtained in all patients with productive cough.
  • Gram-stain and culture should be performed to assess the causative agent and guide the therapy.
  • In approximately 80% of cases of pneumococcal pneumonia the sputum culture is positive.[3]
  • However, the general yield of a sputum sample does not exceed 50-60%.

Blood Culture

  • Blood cultures should be obtained for patients with severe disease, those who require hospitalization, and those who fail antibiotic therapy.
  • Blood cultures may be positive in cases of hematogenous spread, such as S. aureus pneumonia, and in approximately one fourth of patients with pneumococcal pneumonia.
This image depicts the colonial characteristics displayed by Streptococcus pneumoniae bacterial colonies that were grown on primary isolation medium, consisting of trypticase soy agar containing 5% sheep’s blood, as well as 5mg of gentamicin/ml.
Image obtained from CDC PHIL[4]

Other Laboratory Tests

Urine Antigen Test [5]

  • Usually used to diagnose Legionella pneumomnia.
  • Useful also in the diagnosis of pneumonia caused by Streptococcus pneumoniae, with a sensitivity of 74.6%.[6]
  • The Legionella urine antigen can be detected 24 hours after the onset of the symptoms.
  • The more sever the Legionella disease the higher the sensitivity of the urinary antigen test.
  • Urinary antigen testing is not recommended for the diagnosis of pneumococcal pneumonia in children due to the high rate of false-positive results.[7]

Polymerase Chain Reaction

C-Reactive Protein

  • C-reactive protein (CRP) may be helpful to differentiate between bacterial from viral pneumonia.
  • It has been reported that CRP is elevated (> 100 mg/L) in cases of bacterial pneumonia.[8]

Procalcitonin

  • Procalcitonin levels are associated with the severity of the pneumonia.
  • This biomarker also helps to differentiate between bacterial and non-bacterial disease.[9]

Infectious Diseases Society of America/American Thoracic Society consensus recommendation on diagnostics test for etiology of community-acquired pneumonia in adults. [10]

Recommended Diagnostic Tests for Etiology

  • Patients with CAP should be investigated for specific pathogens that would significantly alter standard (empirical) management decisions, when the presence of such pathogens is suspected on the basis of clinical and epidemiologic clues. (Strong recommendation; level II evidence)
  • Routine diagnostic tests to identify an etiologic diagnosis are optional for outpatients with CAP. (Moderate recommendation; level III evidence)
  • Pretreatment blood samples for culture and an expectorated sputum sample for stain and culture (in patients with a productive cough) should be obtained from hospitalized patients with the clinical indications, but are optional for patients without these conditions. (Moderate recommendation; level I evidence)
  • Pretreatment Gram stain and culture of expectorated sputum should be performed only if a good-quality specimen can be obtained and quality performance measures for collection, transport, and processing of samples can be met. (Moderate recommendation; level II evidence)
  • Patients with severe CAP, as defined in the guideline should at least have blood samples drawn for culture, urinary antigen tests for Legionella pneumophila and Streptococcus pneumoniae performed, and expectorated sputum samples collected for culture. For intubated patients, an endotracheal aspirate sample should be obtained. (Moderate recommendation; level II evidence)

For Level of evidence and classes click here.

References

  1. Mandell, L. A.; Wunderink, R. G.; Anzueto, A.; Bartlett, J. G.; Campbell, G. D.; Dean, N. C.; Dowell, S. F.; File, T. M.; Musher, D. M.; Niederman, M. S.; Torres, A.; Whitney, C. G. (2007). "Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults". Clinical Infectious Diseases. 44 (Supplement 2): S27–S72. doi:10.1086/511159. ISSN 1058-4838.
  2. Solomon, Caren G.; Wunderink, Richard G.; Waterer, Grant W. (2014). "Community-Acquired Pneumonia". New England Journal of Medicine. 370 (6): 543–551. doi:10.1056/NEJMcp1214869. ISSN 0028-4793.
  3. Musher, Daniel M.; Thorner, Anna R. (2014). "Community-Acquired Pneumonia". New England Journal of Medicine. 371 (17): 1619–1628. doi:10.1056/NEJMra1312885. ISSN 0028-4793.
  4. {{cite web|url=http://phil.cdc.gov/phil/home.asp%7C title=CDC Public Health Image Library (PHIL)
  5. Couturier MR, Graf EH, Griffin AT (2014). "Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia". Clin Lab Med. 34 (2): 219–36. doi:10.1016/j.cll.2014.02.002. PMID 24856525.
  6. Zalacain R, Capelastegui A, Ruiz LA, Bilbao A, Gomez A, Uranga A; et al. (2014). "Streptococcus pneumoniae antigen in urine: diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adult patients". Respirology. 19 (6): 936–43. doi:10.1111/resp.12341. PMID 24976113.
  7. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C; et al. (2011). "The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America". Clin Infect Dis. 53 (7): e25–76. doi:10.1093/cid/cir531. PMID 21880587.
  8. Flanders, Scott A; Stein, John; Shochat, Guy; Sellers, Karen; Holland, Miles; Maselli, Judith; Drew, W.Lawrence; Reingold, Art L; Gonzales, Ralph (2004). "Performance of a bedside c-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough". The American Journal of Medicine. 116 (8): 529–535. doi:10.1016/j.amjmed.2003.11.023. ISSN 0002-9343.
  9. Johansson, Niclas; Kalin, Mats; Backman-Johansson, Carolina; Larsson, Anders; Nilsson, Kristina; Hedlund, Jonas (2014). "Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity". Scandinavian Journal of Infectious Diseases. 46 (11): 787–791. doi:10.3109/00365548.2014.945955. ISSN 0036-5548.
  10. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG (2007). "Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults". Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 44 Suppl 2: S27–72. doi:10.1086/511159. PMID 17278083. Retrieved 2012-09-06. Unknown parameter |month= ignored (help)

Template:WH Template:WS